Irish patients with blood cancer are the first worldwide to take part in a new drug trial to develop more effective treatment for multiple myeloma, a potentially fatal condition.

An Irish person has become the first in the world to take part in a new drug trial for patients with the blood cancer 'multiple myeloma'.